SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 12b-25

                                              Commission File Number:  000-29057

                           NOTIFICATION OF LATE FILING

      (Check One):  [ ] Form 10-K  [ ] Form 11-K  [ ] Form 20F [X] Form 10-Q

[ ]   Form N-SAR

      For Period Ended:  March 31, 2003
                        --------------
[ ]   Transition Report on Form 10-K        [ ]  Transition Report on Form 10-Q

[ ]   Transition Report on Form 20-F        [ ]  Transition Report on Form N-SAR

[ ]   Transition Report on Form 11-K

      For the Transition Period Ended:
                                      ------------------------------------------

      Read attached  instruction  sheet before  preparing form.  Please print or
type.

      Nothing in this form shall be construed to imply that the  Commission  has
verified any information contained herein.

      If the  notification  relates to a portion of the  filing  checked  above,
identify the item(s) to which the notification relates:
                                                       -------------------------

                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant:        Altrimega Health  Corporation  /d/b/a Creative
                                Holding & Marketing Corp.

Former name if applicable:      N/A

Address of principal executive office
 (Street and number):                   4702 Oleander Drive, Suite 200
City, state and zip code:               Myrtle Beach, South Carolina

                                     PART II
                             RULE 12b-25 (b) AND (c)

        If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)

[X]   (a) The reasons  described in  reasonable  detail in Part III of this form
      could not be eliminated without unreasonable effort or expense;

[X]   (b) The subject annual report,  semi-annual  report,  transition report on
      Form 10-K,  20-F,  11-K or Form N-SAR, or portion thereof will be filed on
      or before the 15th calendar day following the  prescribed due date; or the
      subject  quarterly  report or  transition  report on Form 10-Q, or portion
      thereof will be filed on or before the fifth  calendar day  following  the
      prescribed due date; and

[ ]   (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
      has been attached if applicable.



                                                                     FORM 12b-25

                                    PART III
                                    NARRATIVE

      State below in reasonable  detail the reasons why Form 10-K,  11-K,  10-Q,
N-SAR or the  transition  report  portion  thereof could not be filed within the
prescribed time period. (Attach extra sheets if needed.)

      Registrant   requires  additional  time  to  comply  with  recent  Federal
securities  laws,  particularly  regarding the internal  controls  requirements.
Consequently,  Registrant's  accounting  department  requires additional time to
review its financial  information in order to evaluate  internal  controls,  and
cannot,  without  unreasonable  effort and  expense,  file its Form 10-QSB on or
before the prescribed filing date.  Registrant hopes to obtain all required data
within the next  several  days and,  as a result,  hopes to file the Form 10-QSB
within five days after the prescribed filing date.

                                     PART IV
                                OTHER INFORMATION

      1.  Name and  telephone  number of  person  to  contact  in regard to this
notification:

             John W. Gandy           (843)           497-7028
         ---------------------------------------------------------------
                (Name)            (Area code)   (Telephone number)

      2. Have all other periodic  reports  required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 or Section 30 of the Investment  Registrant
Act of 1940 during the  preceding 12 months or for such shorter  period that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).

                                          [  ] Yes         [X] No

      The  Registrant  has not filed an Amendment to its Form 8-K,  filed August
16, 2002, with respect to Item 2 - Acquisition or Disposition of Assets.

      The  Registrant has not filed an Amendment to its Form 8-K, filed November
13, 2002 with respect to Item 2 - Acquisition or Disposition of Assets.

     The Registrant has not filed its Form 10-KSB for fiscal year ended December
31, 2002.

      3. Is it anticipated that any significant  change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

                                          [  ] Yes         [X] No

      If so: attach an explanation of the anticipated  change,  both narratively
and  quantitatively,  and, if  appropriate,  state the reasons why a  reasonable
estimate of the results cannot be made.


                                       2



                                                                     FORM 12b-25

                          ALTRIMEGA HEALTH CORPORATION
                          ----------------------------
                  (NAME OF REGISTRANT AS SPECIFIED IN CHARTER)

Has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.



Date:  May 15, 2003                         By:  /s/ John W. Gandy
                                               ---------------------------------
                                                 John W. Gandy
                                                 President

           INSTRUCTION.  The form may be signed by an  executive  officer of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature.  If
the  statement  is  signed  on  behalf  of  the   registrant  by  an  authorized
representative   (other   than   an   executive   officer),   evidence   of  the
representative's  authority to sign on behalf of the  registrant  shall be filed
with the form.

                                    ATTENTION

      Intentional misstatements or omissions of fact constitute Federal criminal
violations (see 18 U.S.C. 1001).


                              GENERAL INSTRUCTIONS

      1.  This  form is  required  by  Rule  12b-25  of the  General  Rules  and
Regulations under the Securities Exchange Act of 1934.

      2.  One  signed  original  and  four  confirmed  copies  of this  form and
amendments  thereto must be completed and filed with the Securities and Exchange
Commission,  Washington,  DC 20549,  in accordance  with Rule 0-3 of the General
Rules and Regulations under the Act. The information  contained in or filed with
the form will be made a matter of the public record in the Commission files.

      3. A manually  signed  copy of the form and  amendments  thereto  shall be
filed with each national securities exchange on which any class of securities of
the registrant is registered.

      4. Amendments to the  notifications  must also be filed on Form 12b-25 but
need not restate information that has been correctly  furnished.  The form shall
be clearly identified as an amended notification.

      5.  Electronic  Filers.  This form shall not be used by electronic  filers
unable to timely file a report  solely due to  electronic  difficulties.  Filers
unable to submit a report within the time period  prescribed due to difficulties
in  electronic  filing  should  comply  with  either  Rule  201 or  Rule  202 of
Regulation  S-T or apply for an adjustment in filing date pursuant to Rule 13(b)
of Regulation S-T.

                                       3